Allopregnanolone Decreases Evoked Dopamine Release Differently in Rats by Sex and Estrous Stage

Allopregnanolone Decreases Evoked Dopamine Release Differently in Rats by Sex and Estrous Stage

Mesolimbic dopamine transmission is dysregulated in multiple psychiatric disorders, including addiction. Previous studies found that the endogenous GABAergic steroid (3α,5α)-3-hydroxy-5-pregnan-20-one (allopregnanolone) modulates dopamine levels in the nucleus accumbens and prefrontal cortex. As all...

Full description

Bibliographic Details
Main Authors:	Ana Paula S. Dornellas, Giovana C. Macedo, Minna H. McFarland, Alexander Gómez-A, Todd K. O’Buckley, Claudio Da Cunha, A. Leslie Morrow, Donita L. Robinson
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-01-01
Series:	Frontiers in Pharmacology
Subjects:	neurosteroid allopregnanolone progesterone voltammetry dopamine nucleus accumbens
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2020.608887/full

Similar Items

Effect of progesterone administration in male and female smokers on nicotine withdrawal and neural response to smoking cues: role of progesterone conversion to allopregnanolone
by: Andrew M. Novick, et al.
Published: (2022-10-01)

Deleterious Interaction between the Neurosteroid (3α,5α)3-Hydroxypregnan-20-One (3α,5α-THP) and the Mu-Opioid System Activation during Forced Swim Stress in Rats
by: Giorgia Boero, et al.
Published: (2023-08-01)

Pleiotropic actions of allopregnanolone underlie therapeutic benefits in stress-related disease
by: Giorgia Boero, et al.
Published: (2020-05-01)

Allopregnanolone: Regenerative therapeutic to restore neurological health
by: Gerson D. Hernandez, et al.
Published: (2022-11-01)

Allopregnanolone Promotes Migration and Invasion of Human Glioblastoma Cells through the Protein Tyrosine Kinase c-Src Activation
by: Carmen J. Zamora-Sánchez, et al.
Published: (2022-04-01)

Associations between PTSD-Related extinction retention deficits in women and plasma steroids that modulate brain GABAA and NMDA receptor activity
by: Suzanne L. Pineles, et al.
Published: (2020-11-01)

Progesterone in the Brain: Hormone, Neurosteroid and Neuroprotectant
by: Rachida Guennoun
Published: (2020-07-01)

The Enantiomer of Allopregnanolone Prevents Pressure-Mediated Retinal Degeneration Via Autophagy
by: Makoto Ishikawa, et al.
Published: (2022-03-01)

Allopregnanolone and Neuroinflammation: a Focus on Multiple Sclerosis
by: Farshid eNoorbakhsh, et al.
Published: (2014-06-01)

Divergent Transcriptomic Effects of Allopregnanolone in Postpartum Depression
by: Sarah A. Rudzinskas, et al.
Published: (2023-06-01)

Biosynthesis and biological action of pineal allopregnanolone
by: Kazuyoshi eTsutsui, et al.
Published: (2014-05-01)

Biosynthesis, mode of action and functional significance of neurosteroids in the Purkinje cell
by: Kazuyoshi eTsutsui, et al.
Published: (2011-10-01)

Neurosteroids and their role in sex-specific epilepsies
by: Doodipala Samba Reddy
Published: (2014-12-01)

Novel receptor targets for production and action of allopregnanolone in the central nervous system: a focus on pregnane xenobiotic receptor
by: Cheryl A Frye, et al.
Published: (2014-04-01)

Allopregnanolone in Postpartum Depression
by: Graziano Pinna, et al.
Published: (2022-04-01)

Microglial Cell Morphology and Phagocytic Activity Are Critically Regulated by the Neurosteroid Allopregnanolone: A Possible Role in Neuroprotection
by: Valérie Jolivel, et al.
Published: (2021-03-01)

Allopregnanolone: Metabolism, Mechanisms of Action, and Its Role in Cancer
by: Carmen J. Zamora-Sánchez, et al.
Published: (2022-12-01)

Early postnatal allopregnanolone levels alteration and adult behavioral disruption in rats: Implication for drug abuse
by: Iris Bartolomé, et al.
Published: (2020-05-01)

Chronic intermittent ethanol exposure alters stress effects on (3α,5α)-3-hydroxy-pregnan-20-one (3α,5α-THP) immunolabeling of amygdala neurons in C57BL/6J mice
by: Antoniette M Maldonado-Devincci, et al.
Published: (2016-03-01)

Trajectories of Allopregnanolone and Allopregnanolone to Progesterone Ratio across the Six Subphases of Menstrual Cycle
by: Ajna Hamidovic, et al.
Published: (2023-04-01)

Neuroprotective actions of cerebellar and pineal allopregnanolone on Purkinje cells
by: Kazuyoshi Tsutsui, et al.
Published: (2020-03-01)

Estrous cycle and stress: influence of progesterone on the female brain
by: T.A. Lovick
Published: (2012-04-01)

Estrous cycle and stress: influence of progesterone on the female brain
by: T.A. Lovick
Published: (2012-04-01)

Neurosteroids and Focal Epileptic Disorders
by: Maxime Lévesque, et al.
Published: (2020-12-01)

Neurosteroid Actions in Memory and Neurologic/Neuropsychiatric Disorders
by: Marcia H. Ratner, et al.
Published: (2019-04-01)

A Potential Mechanism Underlying the Therapeutic Effects of Progesterone and Allopregnanolone on Ketamine-Induced Cognitive Deficits
by: Ting Cao, et al.
Published: (2021-03-01)

Endoplasmic reticulum stress, autophagy, neuroinflammation, and sigma 1 receptors as contributors to depression and its treatment
by: Chika Fujii, et al.
Published: (2024-01-01)

Zuranolone – synthetic neurosteroid in treatment of mental disorders: narrative review
by: Rafał Marecki, et al.
Published: (2023-12-01)

Serum levels of allopregnanolone in migraine patients: A case–control study
by: Makpere Delikanli, et al.
Published: (2021-01-01)

Human Microglia Synthesize Neurosteroids to Cope with Rotenone-Induced Oxidative Stress
by: Chiara Lucchi, et al.
Published: (2023-04-01)

PPAR and functional foods: Rationale for natural neurosteroid-based interventions for postpartum depression
by: Francesco Matrisciano, et al.
Published: (2020-05-01)

Neurosteroids and GABAergic signaling in health and disease
by: MacKenzie Georgina, et al.
Published: (2013-02-01)

Role of anticonvulsant and antiepileptogenic neurosteroids in the pathophysiology and treatment of epilepsy
by: D. Samba eReddy
Published: (2011-10-01)

Realising the therapeutic potential of neuroactive steroid modulators of the GABAA receptor
by: Delia Belelli, et al.
Published: (2020-05-01)

(3α,5α)3-Hydroxypregnan-20-one (3α,5α-THP) Regulation of the HPA Axis in the Context of Different Stressors and Sex
by: Giorgia Boero, et al.
Published: (2022-08-01)

Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle
by: Liisa Hantsoo, et al.
Published: (2020-05-01)

Allopregnanolone in postpartum depression: Role in pathophysiology and treatment
by: Samantha Meltzer-Brody, et al.
Published: (2020-05-01)

The Allopregnanolone Response to Acute Stress in Females: Preclinical and Clinical Studies
by: Maria Giuseppina Pisu, et al.
Published: (2022-09-01)

Inhibition of human macrophage activation via pregnane neurosteroid interactions with toll-like receptors: Sex differences and structural requirements
by: Irina Balan, et al.
Published: (2022-07-01)

Pineal Neurosteroids: Biosynthesis and Physiological Functions
by: Shogo Haraguchi, et al.
Published: (2020-08-01)